Tumor targeting using liposomal antineoplastic drugs

160Citations
Citations of this article
167Readers
Mendeley users who have this article in their library.

Abstract

During the last years, liposomes (microparticulate phospholipid vesicles) have been used with growing success as pharmaceutical carriers for antineoplastic drugs. Fields of application include lipid-based formulations to enhance the solubility of poorly soluble antitumor drugs, the use of pegylated liposomes for passive targeting of solid tumors as well as vector-conjugated liposomal carriers for active targeting of tumor tissue. Such formulation and drug targeting strategies enhance the effectiveness of anticancer chemotherapy and reduce at the same time the risk of toxic side-effects. The present article reviews the principles of different liposomal technologies and discusses current trends in this field of research. © 2008 Dove Medical Press Limited. All rights reserved.

Cite

CITATION STYLE

APA

Huwyler, J., Drewe, J., & Krähenbühl, S. (2008). Tumor targeting using liposomal antineoplastic drugs. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s1253

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free